Although some data support the association between CHFR promoter methylation and better outcomes (29), other studies have correlated CHFR methylation with worse progression-free survival (PFS) and overall survival (OS), having even been proposed as an independent predictor of recurrence in colorectal adenocarcinoma (30). This evidence concerns the gene CHFR and colorectal adenocarcinoma.